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Abstract The risk for multifactorial diseases is deter-
mined by risk factors that frequently apply across disorders
(universal risk factors). To investigate unresolved issues on
etiology of and individual’s susceptibility to multifactorial
diseases, research focus should shift from single determi-
nant-outcome relations to effect modification of universal
risk factors. We present a model to investigate universal risk
factors of multifactorial diseases, based on a single risk
factor, a single outcome measure, and several effect modi-
fiers. Outcome measures can be disease overriding, such as
clustering of disease, frailty and quality of life. ‘‘Life course
epidemiology’’ can be considered as a specific application of
the proposed model, since risk factors and effect modifiers of
multifactorial diseases typically have a chronic aspect. Risk
factors are categorized into genetic, environmental, or
complex factors, the latter resulting from interactions
between (multiple) genetic and environmental factors (an
example of a complex factor is overweight). The proposed
research model of multifactorial diseases assumes that
determinant-outcome relations differ between individuals
because of modifiers, which can be divided into three cate-
gories. First, risk-factor modifiers that determine the effect
of the determinant (such as factors that modify gene-
expression in case of a genetic determinant). Second, out-
come modifiers that determine the expression of the studied
outcome (such as medication use). Third, generic modifiers
that determine the susceptibility for multifactorial diseases
(such as age). A study to assess disease risk during life
requires phenotype and outcome measurements in multiple
generations with a long-term follow up. Multiple genera-
tions will also enable to separate genetic and environmental
factors. Traditionally, representative individuals (probands)
and their first-degree relatives have been included in this
type of research. We put forward that a three-generation
design is the optimal approach to investigate multifactorial
diseases. This design has statistical advantages (precision,
multiple-informants, separation of non-genetic and genetic
familial transmission, direct haplotype assessment, quantify
genetic effects), enables unique possibilities to study social
characteristics (socioeconomic mobility, partner prefer-
ences, between-generation similarities), and offers practical
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benefits (efficiency, lower non-response). LifeLines is a
study based on these concepts. It will be carried out in a
representative sample of 165,000 participants from the
northern provinces of the Netherlands. LifeLines will con-
tribute to the understanding of how universal risk factors are
modified to influence the individual susceptibility to multi-
factorial diseases, not only at one stage of life but
cumulatively over time: the lifeline.
Keywords Multifactorial disease  Effect modification 
Gene–environment  Biobank
Introduction
Multifactorial diseases are by definition the result of multiple
risk factors that are both genetically and environmentally
determined. Examples of multifactorial diseases are
depression, COPD, cancer, cardiovascular and endocrine
diseases. Together they comprise the most common disor-
ders in adulthood and are responsible for the use of the
majority of health care resources [1]. Biomedical and epi-
demiological research on the etiology of multifactorial
diseases frequently focuses on single determinant—outcome
relations, without taking into account other risk factors, other
diseases and time dependent effects. This has been recog-
nized over the last years and resulted in new study designs
sometimes referred to as ‘‘life course epidemiology’’ [2].
Multifactorial diseases may have more in common than
generally recognized since similar risk factors are associ-
ated with multiple diseases, as has been shown for example
by low birth weight [3]. A risk factor like smoking results
in lung cancer in some individuals and myocardial infarc-
tion in others, whereas it has a protective effect on
Parkinson’s disease, suggesting an individual susceptibility
for specific risk factors [4, 5]. The individual differences
that determine which disease occurs in the presence of a
given universal risk factor are called modifiers [6].
Since different diseases share identical risk factors, it is
clear that a continuing exclusive focus on associations
between single risk factors and single outcomes will not
unravel the unresolved issues of etiology and individual
prognosis of multifactorial diseases. Instead, research has
to focus on the underlying mechanisms why individuals
with similar (established) risk factors develop different
diseases, i.e. the modification of the universal risk factors
for multiple disorders [7].
In this paper we present a model based on effect mod-
ification to investigate universal risk factors and their
modifiers of multifactorial diseases. We also discuss the
three-generation design, which provides optimal methods
to study the interplay of genetic and environmental risk
factors.
Research model for multifactorial diseases
The proposed model to investigate universal risk factors of
multifactorial diseases is based on a single (universal) risk
factor, a single outcome measure (which may refer to
multiple diseases, see below), and several effect modifiers.
This research model is summarized in Fig. 1. Risk factors
can be categorized into genetic, environmental or complex
factors, the latter resulting from interactions between
(multiple) genetic and environmental factors. Examples of
complex factors are overweight and personality traits. In
the same way, we distinguish effect modifiers as genetic,
environmental and complex modifiers.
It is important to realize that the same factor can be risk
factor in one research question but modifier or outcome in
another research question. The research question deter-
mines the role of the included factors. Like all models, the
proposed research model of risk factor—modifier—out-
come (Fig. 1) is a simplification to understand the
underlying pathophysiology. Especially the time dependent
effect of modification needs careful attention: the suscep-
tibility of an individual for the effects of a risk factor may
differ during the lifeline. The research model is based on
risk and not on causation, like for example Rothman’s pie
model of sufficient cause [6]. Within Rothman’s scheme
the proposed model explains why individuals with a similar
component cause (risk factor) may develop different
diseases.
Research models for multifactorial diseases can be dis-
tinguished into disorder-specific, latency and pathway
models. The disorder-specific models for morbidity accu-
mulation constitute the basis of most biomedical research
and of medical superspecialisation [8–10]. They focus on
single outcomes. For example, low birth weight raises the
risk of COPD and, in turn, COPD (for example due to the
stress associated with being a COPD patient) raises the risk
of depression. Low birth weight needs only to be linked
with the first problem in this chain to fully explain the
association between birth weight and depression. In these
chains-of-risk models, risk factors are disorder specific. In
contrast, latency models propose a disorder-generic liabil-
ity to whichever morbidity as a stable programmed
individual feature, related to early events and genetic
influences [3, 11, 12]. The link of low birth weight with
both COPD and depression is, in these models, taken to
indicate that it raises the risk of each of them irrespective
Risk factor Disease/Endophenotype (early pathology)
Modifiers
Fig. 1 The role of modifiers in the research model for multifactorial
diseases
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of whether the other is experienced. From this point of
view, not only morbidity but also an individual’s lifespan is
determined early on. Finally, pathway models like the
proposed research model of risk factor-modifier-outcome,
are models that allow for the fact that disease susceptibility
needs not be stable but may change over time in response
to illness, life styles or advancing age [13]. In fact, ‘‘life
course epidemiology’’ can be regarded as a specific
application of our proposed research model [2]. Outcome at
a certain age can constitute a risk factor or a modifier at a
later age.
Genetic risk factors
Genetic risk factors are defined as changes in the base pair
sequence of the human genome, which do not change during
life. In the previous decade, genetic association studies have
generated many data concerning the genetic basis of multi-
factorial diseases. Several genetic polymorphisms have been
linked to more than one disease, examples are polymor-
phisms in the ACE, TGF-b and TNF-a genes [14–16]. Even
if specific polymorphisms have only been linked to a single
disease, often different mutations in the same gene are
related to other diseases, supporting the idea of common
pathways in different multifactorial diseases.
Environmental risk factors
Environmental risk factors are experienced throughout life.
They vary from life events to air pollution and medical
interventions. The rapid change of morbidity patterns
within one or two generations clearly illustrates the
importance of environmental factors in the development,
progression and remission of multifactorial diseases.
Exposure to ‘‘western lifestyle’’ is frequently blamed for
the increase in prevalence of many of these disorders over
the past decades [17]. Some diseases have a well-estab-
lished environmental risk factor, which explains a large
proportion of disease risk. For instance cigarette smoking is
associated with COPD (90% of COPD patients have sig-
nificant smoking history) [18], and major life events
increase the risk for depression [19, 20]. Though these
associations have been clearly established, still details of
the pathophysiologic pathways have been elucidated
insufficiently.
As mentioned above, environmental risk factors include
medical interventions (drugs, surgery, psychological con-
sultations, etc.) and exposure to life style factors (diet,
smoking, physical activity). These environmental factors
are (thought to be) modifiable and often used in clinical
practice and intervention studies. In contrast, other
environmental risk factors are more or less ‘fixed’, like past
environmental experiences (intra-uterine environment;
exposures at day care center, school and occupation) and
macro-environmental exposures (air pollution).
Socioeconomic status (SES) is an intriguing complex
risk factor for multivariate diseases. It has a strong envi-
ronmental component, but genetic factors may be involved
as well [21]. Several studies have indicated that SES
affects the onset of diseases through a higher prevalence of
risk factors like hypertension and obesity among people
with lower SES. An alternative hypothesis proposes that
lower socioeconomic status is (at least partly) caused by ill
health instead of the other way around [22].
Complex risk factors
The origin of many risk factors is not entirely genetic or
environmental but the result of interactions between genes
and environmental factors. The interaction between mul-
tiple genetic and/or environmental factors can result in
(endo)phenotypic characteristics, which in the proposed
model are referred to as complex risk factors. Examples are
body weight, personality traits, and plasma cortisol level.
This also include epigenetic changes: environmental fac-
tors that result in phenotypic changes in gene expression
without altering the genotype [23]. Often the interaction
between genetic and environmental risk factors resulting in
a complex risk factor is not completely elucidated, even
though the role of this complex factor as risk factor for
disease development has been established, for example by
proven benefit from intervention on this factor. Selected
multifactorial diseases are largely explained by a single
complex risk factor, for example obesity and type 2 dia-
betes mellitus [24]. Because of their well-defined
pathophysiologic role, numerous biomedical and epidemi-
ological studies focus on determinants of and interventions
on complex risk factors.
Effect modifiers
The risk of a genetic, environmental or complex factor on
the occurrence of disease often differs between individuals
as well as between different stages of an individual’s life.
Similar risk factors result in separate multifactorial dis-
eases in different individuals, which can be explained by
modifying factors. This notion forms the basis for the
proposed research model (Fig. 1). Modifiers explain the
difference in effect of a risk factor between individuals or
even within an individual over time. It is the challenge of
future biomedical and epidemiological research to unravel
the role of modifiers in multifactorial diseases. As
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mentioned above, the same factor can be risk factor in one
research question but modifier or outcome in another
research question.
Effect modifiers can be divided into three categories, by
referring to three different parts of the pathophysiologic
mechanisms of a disease (Fig. 2). First, risk-factor modi-
fiers that change the effect of the determinant (such as renal
function and factors that modify gene-expression in case of
a genetic determinant), which is sometimes referred to as
homeostatic switch. Second, outcome modifiers that
determine the expression of the studied outcome (such as
medication use, immune-status). Third, generic modifiers
that determine the susceptibility for multifactorial diseases
(such as age, socioeconomic status). These categories are
based on pathophysiologic mechanisms; the statistical
approach is similar for all modifiers.
Apart from their direct effects on different parts of the
pathophysiologic pathway of a disease, modifiers may have
a time-dependent effect. The same factor that occurs during
childhood will change susceptibility differently than when
occurring at older ages.
Statistical methods to model different effects of a
modifier over time have been developed for ‘‘life course
epidemiology’’ [2].
Outcomes
Research on multifactorial disease tends to focus on single
outcomes, typically clinically defined diseases like diabe-
tes, myocardial infarction, depression, dementia and
COPD. Although these concepts are relevant in clinical
care in order to make decisions on treatment, the distinc-
tion between presence and absence of a multifactorial
clinical disease is often not clearly defined. Thus a diag-
nosis may be insufficiently clear-cut for genetic purposes
(e.g. in case the disease becomes only clinically apparent at
older age, but is present already at earlier age) and as a
consequence obscures the true underlying mechanism. In
that case, subphenotypes are often used to overcome the
bias of a doctor’s diagnosis. In the same way, hospital-
ization and mortality are attractive measures, but their
cause does not exclusively depend on the disease under
study alone. On the other hand, many diseases are defined
by an arbitrary cut-off in a continuous disease marker or
endophenotype like plasma glucose level, serum IgE or
score on a depression scale.
More importantly, like the principal shortcoming of
using single determinants in research on multifactorial
disease one should apply multiple outcome measures.
Comorbidity (when a certain index disorder is accompa-
nied by one or more other disorders [25] or multimorbidity
(concurrence of two or more medical conditions within a
person) [26] is ubiquitous in clinical practice of multifac-
torial diseases. It has been well established that the
proportion of people with multiple diseases may vary from
30% in the general population [27] to over 50% in people
aged 60 years and older [28]. The presented research
model (Fig. 1) includes a single outcome measure. There
are two approaches to investigate co-morbidity in this
model, depending on the research question. A first
approach is to define clustering of disease as a separate
endpoint (either related disorders like diabetes and ampu-
tation, or presumably non-related like arthritis and cancer).
This assumes that a specific combination of risk factors and
modifiers results in a specific combination of disorders.
A second approach to quantify multifactorial disease in















Fig. 2 Effect modifiers
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process (for example inflammation) or a marker of burden
of disease, such as the Chronic Disease Score [29]. Other
terms applied in the literature for the burden of disease
include disability, quality of life, and frailty. Although
these are used interchangeably, they refer to different
entities with each a distinct content [30]. Disability is
defined as the difficulty to carry out activities of daily
living, but can also be viewed as social phenomenon [31]
Quality of life can be defined both from societal (including
income, employment, housing, education) and individual
perspective (including personal experiences and values,
happiness, life satisfaction) [32]. Frailty is defined as a
state of increased physiologic vulnerability for adverse
health outcomes, characterized by wasting, loss of endur-
ance, decreased mobility and potentially decreased
cognitive function [33]. Frailty is associated with chrono-
logical ageing and is equated to an increased risk of death.
It can be regarded as biological, as opposed to chrono-
logical age [34]. Therefore, frailty might be the preferred
generic measure of (multifactorial) disease when consid-
ering modification of risk factors. Also longevity might be
a suitable general outcome measure [35].
Study design
The investigation of effect modification on development of
disease requires dedicated study design solutions, princi-
pally a large sample size to allow for stratified analyses. In
addition, assessing risk factors during life requires a long-
term follow up, with measurements in multiple genera-
tions. The advantage of including more generations is the
possibility to separate genetic and environmental factors.
Traditionally, representative individuals (probands) and
their first-degree relatives have been included in this type
of research. A three-generation study design goes a step
further by including also the partner of the proband and his/
her parents (if present) as well as the children of the pro-
band (if any). This design has statistical advantages with
respect to multiple-level information, separation of non-
genetic and genetic familial transmission and direct hap-
lotype assessment. In addition, because of the inclusion of
step-family members it the design enables to quantify
genetic effects [36]. Furthermore it opens unique possi-
bilities to study social characteristics (socioeconomic
mobility, partner preferences, between-generation similar-
ities), and offers practical benefits (lower non-response).
An overview of these aspects is given in Table 1.
Another phenomenon that can be studied within this
design is ‘‘assortative mating’’ (partner preference), the
selection of partners based on (patho)physiological char-
acteristics. This contributes to the concentration within
particular families of genetic and environmental risk
factors. There is substantial evidence that assortative mat-
ing affects height, physical attractiveness, SES, ethnicity,
religion, social attitudes, and particular behaviors like
antisocial behavior [37]. Estimating the size of this phe-
nomenon enables better interpretation of the relevance of
(absence of) effect modification.
An additional advantage of a three-generation design is
the wide age range of the participants. This allows ascer-
taining (pre-clinical) events at an early age thereby
providing insight into time-dependent effects. Furthermore,
a variety of exposures that affect disease development at a
different age can be examined, an important aspect since
exposures often vary by age. Also, genotype-exposure
interaction can be examined stratified by age.
Outline of the LifeLines project
Based on the reviewed concepts of modifiers and three-
generation design we have developed a cohort study to
investigate universal risk factors and their modifiers for
multifactorial diseases: LifeLines. This study may result in
better understanding of the causes and prognosis of burden
of disease over lifetime and may ultimately result in opti-
mal tailored treatment of individual diseases and disease
overriding preventive strategies. Specific research ques-
tions will focus on risk factors and modifiers (genetic,
environmental and complex factors) for single and multiple
diseases. Rather than co-morbidity, LifeLines focuses on
co-determinants. Compared to large scale genetic epide-
miological studies like Biobank UK and deCODE Iceland,
LifeLines includes more detailed measurements of envi-
ronmental factors, as well as changes of risk factors,
assessment of endophenotypes and incidence of disease.
Secondary aims include the assessment of the preva-
lence and incidence of multifactorial diseases and their risk
factors in individuals as well as in families. The burden of
disease for the society will be quantified in terms of care
needed.
LifeLines is an observational follow-up study in a large
representative sample of the population of the northern
provinces of the Netherlands covering three generations.
Firstly, a random sample of persons aged between 25 and
50 years are invited to participate. Subsequently their
family members if present are invited to also take part
(parents, partner, parents in law, children), resulting in a
three-generation study.
The core of the LifeLines project consists of dedicated
data collection and biological sample storage, including
genetic samples (‘‘biobank’’). All participants receive a
number of questionnaires and a basic medical examination
and are followed for many years with extensive standard-
ized measurements.
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A cohort study, in contrast to a case-control study,
enables the prospective investigation of risk factors,
which is crucial in the study of environmental and other
time-varying exposures, as well as interactions between
environmental risk factors [38]. For genetic studies a case-
control design is often more appropriate, but in such a
design it is virtually impossible to investigate gene–
environment interactions.
Sample size
The LifeLines project will include 165,000 participants:
anticipated to consist of approximately 45,000 probands,
30,000 partners, 55,000 parents (in law) and 35,000 chil-
dren. This number is based on balancing costs and practical
limitations with sufficient number of incident diseases.
When estimating the number of events one has to realize
that sick individuals are less likely to participate. Follow-
ing the adjustment for this ‘‘Hawthorne effect’’ as
suggested by the UK Biobank [39], after 5 years of follow-
up the expected incident cases of some common
multifactorial diseases in this cohort are 1,000 individuals
with myocardial infarctions, 500 with stroke, 2,000 with
depression. Based on a prevalence of 20–40% of the risk
factors of interest, and estimated relative risk around 1.2,
these numbers are sufficient to identify statistically sig-
nificant associations. Newly developed statistical methods
to analyze combinations of (genetic) risk factors will
improve the effectiveness of these databases [40].
However, the main objective for LifeLines is to inves-
tigate effect modification, or interaction in statistical terms.
By performing stratified analyses or introducing more
additional terms into a regression model, each with its own
variation, the required number of participants increases
substantially. This is only partly compensated by the fact
that these analyses will typically use continuous measures
as outcome (endophenotype). The power calculations for
these analyses are strongly influenced by the interaction
ratio, which is often not known.
Methods of data collection are matched with other
ongoing biobank studies (P3G consortium) [41], which
enables combining datasets to construct large study
populations.
Table 1 Advantages of a three-generation study design
Statistical advantages
Haplotype assessment The inclusion of both parents enables the direct assessment of
haplotypes, which is usually not possible in population-based
studies.
Multi-informants Family members can provide data on individual characteristics and on
shared environmental exposures. Multi-informant data permits to
estimate and reduce information source bias and to increase the
reliability in assessing phenotypes.
Family-wide effects Family-wide effects can be examined at three levels by means of
multilevel statistical methods: the marital relationship
(proband + partner), the primary family (proband, partner, and
offspring living at home) and the extended family (proband,
partner, their parents and offspring).
Quantitative genetics Possibility to perform quantitative genetics.
Separation of non-genetic (cultural) and genetic familial transmission The difference between the familial and genetic loadings helps to
disentangle the familial similarity in genetic and non-genetic
transmitted components.
Unique possibilities to study social patterns
Between-generation (dis)similarities The transmission of severity and specificity of a particular trait or
disorder from (grand)mother and/or (grand)father can be examined.
It also enables to distinguish individual behavioral changes versus
changes due to external effects like cultural changes or legislation.
Socioeconomic mobility The three-generation design offers the unique possibility to examine
socioeconomic mobility.
Assortative mating The effects of assortative mating on a variety of individual
characteristics can be investigated, ranging from the
(patho)physiological to the psychosocial domains.
Practical benefits
Reduction of non-response and attrition It seems likely that it is easier to maintain the cohort if it consists of
family members as compared to non-related individuals.
Participation in the study could become sort of family activity.
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Conclusion
Large-scale biobank studies have recently been started in
the United Kingdom (the UK BioBank), Iceland
(deCODE), Estonia, Germany, Canada and Japan. There
are serious plans to start a biobank study in the United
States [42]. Most of these projects are focused on DNA and
collect only limited data on environmental factors. As
recognized by the NIH, population based studies on mul-
tifactorial diseases should include both genetic and
environmental factors on a population basis, and focus on
identifying genetic and environmental modifiers of this risk
(gene-gene and gene–environment interactions) [42].
For the assessment of multifactorial diseases it is
important to understand how the interaction between uni-
versal risk factors and specific modifiers, e.g. risk-factor
modifiers, outcome modifiers, and generic modifiers,
accounts for the development of multifactorial disease in
individuals. The explicit aim of Lifelines, to investigate
risk factors that apply across disorders, is at odds with
common practice of biomedical research that strongly
focuses on single disease entities. LifeLines constitutes to
our opinion a large step forward and a challenge to better
understanding of the origins of health and disease cumu-
latively over time: the lifeline.
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